Modulation of adenylyl cyclase activity in rat striatal homogenate by dopaminergic receptors

Journal of Pharmacological Sciences

Volumn 108, Issue 1, 2008, Pages 63-70

  Vonk, Argo ^a   Reinart, Reet ^a   Rinken, Ago ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Adenylyl cyclase; cAMP; Dopamine D1 receptor; Rat striatum; Subtype selective assay

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3 (1 ADAMANTYL) 1 AMINOMETHYL 3,4 DIHYDRO 5,6 DIHYDROXY 1H 2 BENZOPYRAN; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; BUTACLAMOL; CYCLIC AMP; DIHYDREXIDINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; QUINPIROLE; RACLOPRIDE; SULPIRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; LIGAND BINDING; NONHUMAN; RAT;

EID: 52949104349     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08019FP     Document Type: Article

References (35)

1. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78:189-225.
2. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, et al. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A. 1993;90:8861-8865.
3. Deng YP, Lei WL, Reiner A. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat. 2006;32:101-116.
4. Harro J, Oreland L. Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res Rev. 2001;38:79-128.
5. Wieland T, Jakobs KH. Measurement of receptor-stimulated guanosine 5′-O-(γ-thio)triphosphate binding by G proteins. Meth Enzymol. 1994;237:3-13.
6. Gierschik P, Bouillon T, Jakobs KH. Receptor-stimulated hydrolysis of guanosine 5′-triphosphate in membrane preparations. Meth Enzymol. 1994;237:13-26.
7. 35S]GTPγS binding in rat striatal membranes. Biochem Pharmacol. 1999;57:155-162.
8. 35S] GTPγS binding assays. Trends Pharmacol Sci. 2003;24:87-90.
9. Cussac D, Pasteau V, Millan MJ. Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine. Eur J Pharmacol. 2004;485:111-117.
10. laCour CM, Vidal S, Pasteau V, Cussac D, Millan MJ. Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists. Neuropharmacology. 2007;52:1003-1014.
11. Johnson RA, Salomon Y. Adenylyl cyclase, G proteins, and guanylyl cyclase. Assay of adenylyl cyclase catalytic activity. Meth Enzymol. 1991;195:3-21.
12. Mallo T, Matrov D, Herm L, Koiv K, Eller M, Rinken A, et al. Tickling-induced 50-kHz ultrasonic vocalization is individually stable and predicts behaviour in tests of anxiety and depression in rats. Behav Brain Res. 2007;184:57-71.
13. Nordstedt C, Fredholm BB. A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal Biochem. 1990;189:231-234.
14. 35S]GTPγS binding to membrane preparations of rat frontal cortex. Neurochem Res. 2008;33:477-482.
15. 1 receptors in Sf9 cells requires expression of Gi proteins. Neurosci Lett. 2006;406:169-173.
16. 3H]-raclopride binding to dopamine D2 receptors and D2 receptor-G protein interaction in the rat striatum. Brain Res. 2003;976:209-216.
17. Lepiku M, Rinken A, Järv J, Fuxe K. Kinetic evidence for isomerization of the dopamine receptor-raclopride complex. Neurochem Int. 1996;28:591-595.
18. 3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. J Pharmacol Exp Ther. 1989;250:696-706.
19. 2+ and enhancing its extent of activation by guanine nucleotides. Proc Natl Acad Sci U S A. 1982;79:5179-5183.
20. 2A receptors. Proc Acad Sci Estonia (Chemistry). 2004;53:153-164.
21. 3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: evidence for heterogeneities in affinity states and cortical distribution. J Neurochem. 1988;50:451-463.
22. Chu J, Wilczynski W, Wilcox RE. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens. Brain Behav Evol. 2001;57:328-342.
23. DeNinno MP, Schoenleber R, Perner RJ, Lijewski L, Asin KE, Britton DR, et al. Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4- dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor. J Med Chem. 1991;34:2561-2569.
24. Mottola DM, Brewster WK, Cook LL, Nichols DE, Mailman RB. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist. J Pharmacol Exp Ther. 1992;262:383-393.
25. Terasmaa A, Andbjer B, Fuxe K, Rinken A. Striatal dopamine denervation decreases the GDP binding affinity in rat striatal membranes. Neuroreport. 2000;11:2691-2694.
26. 2 receptor binding in rats. Pharmacol Toxicol. 2000;86:197-202.
27. Alttoa A, Koiv K, Eller M, Uustare A, Rinken A, Harro J. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity. Neuroscience. 2005;132:979-990.
28. Stoof JC, Kebabian JW. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 1981;294:366-368.
29. 0 G proteins: evidence for agonist regulation of G protein selectivity. Br J Pharmacol. 2003;138:775-786.
30. Taussig R, Tang WJ, Hepler JR, Gilman AG. Distinct patterns of bidirectional regulation of mammalian adenylate cyclases. J Biol Chem. 1994;269:6093-6100.
31. 2 adenosine receptors: Their presence and neuromodulatory role in the central nervous system. Gen Pharmacol. 1996;27:925-933.
32. 2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A. 1991;88:7238-7241.
33. Childers SR, LaRiviere G. Modification of guanine nucleotide-regulatory components in brain membranes. II. Relationship of guanosine 5′-triphosphate effects on opiate receptor binding and coupling receptors with adenylate cyclase. J Neurosci. 1984;4: 2764-2771.
34. Rashid AJ, So CH, Kong MM, Furtak T, El Ghundi M, Cheng R, et al. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A. 2007;104:654-659.
35. 50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099-3108.